The Danish company of Biotechnology Bavarian Nordic has announced a turnover superior to the forecasts for the first quarter. The operating result has returned to profits.
Turnover increased by 62.1 % to 1,347 million Danish crowns (831). This result is comparable to the consensus of analysts, which settled at 995.
The depreciation before depreciation amounted to 419.5 million Danish crowns (21.8), with a margin before depreciation of 31.1 % (2.6). The expected margin was 15 %.
The operating profit amounted to 258.9 million Danish crowns (-128.9). The operating margin was 19.2 %.
-The result after taxes amounted to 218.8 million Danish crowns (-114.5).
The result per share amounted to 2.7 Danish crowns (-1.5).
Bavarian Nordic reiterates its turnover forecasts from 5.6 to 6.7 billion Danish crowns and a margin of Ebitda from 26 to 30 %.
| Bavarian Nordic, Mdkk | T1-2025 | Consensus | Variation in relation to consensus | T1-2024 | Variation |
| Net turnover | 1 347 | 995 | 35,4 | 831 | 62,1 |
| Ebitda | 419,5 | 21,8 | 1 824,3 | ||
| Marge D’Ebitda | 31,1 | 2 | |||
| Operating profit | 258,9 | -128,9 | |||
| Operating margin | 19 | ||||
| Result | 218,8 | -114,5 | |||
| Result by action, DKK | 2,7 | -1,5 |
Consensual data provided by the company
